Windward Bio Group AG Common Shares (WWB) Stock Price

Windward Bio Group AG Common Shares Price

NYSE·CLOSED
22.64
​
Market closed

Windward Bio Group AG Common Shares stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Windward Bio Group AG Common Shares business model & stock analysis

Windward Bio Group AG operates as a clinical stage biotechnology company that develops ultra-long-acting antibody medicines for patients with respiratory and dermatologic diseases. Its drug candidates WIN378, an ultra-long-acting and novel fully human monoclonal antibody, which has completed Phase I clinical study that inhibits thymic stromal lymphopoietin (TSLP); and WIN027, an ultra-long-acting bispecific antibody that is in Phase I clinical study simultaneously targets TSLP and interleukin-13 (IL-13) and two clinically validated drivers of inflammatory disease. The company has collaboration agreements with Sichuan Kelun-Biotech BioPharmaceutical Co., Ltd, Harbour BioMed (Shanghai) Co., Ltd, and Qyuns Therapeutics Co., Ltd. Windward Bio Group AG was incorporated in 2024 and is based in Basel, Switzerland.

Frequently asked questions about Windward Bio Group AG Common Shares

Converted at the current exchange rate, the Windward Bio Group AG Common Shares share trades at 20.63 EUR (22.64 USD).

The revenue cannot currently be calculated for Windward Bio Group AG Common Shares.

The profit cannot currently be calculated for Windward Bio Group AG Common Shares.

The P/E ratio cannot be calculated for Windward Bio Group AG Common Shares at the moment.

The P/S cannot be calculated for Windward Bio Group AG Common Shares currently.

The Eulerpool Quality Score for Windward Bio Group AG Common Shares is 2/10.

The ISIN of Windward Bio Group AG Common Shares is CH1623933509. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Windward Bio Group AG Common Shares is WWB. The ticker symbol is used to trade Windward Bio Group AG Common Shares shares on the stock exchange.

Fair ValueTerminal
20.38 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
-
Industry
N/A
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Nov 13, 2026
ISIN
CH1623933509
Market capitalization
1.31 B USDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
6.83
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-25.12 %
Last updated Nov 19, 2026, 6:48 AM

Windward Bio Group AG Common Shares Peer Group